[Regression of experimental tumours in mice by treatment with two cAMP analogues (author's transl)].
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D003994:Bucladesine / Q000627:therapeutic use*; D000242:Cyclic AMP / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D012878:Skin Neoplasms / Q000139:chemically induced / Q000188:drug therapy*
D015127:9,10-Dimethyl-1,2-benzanthracene; D003994:Bucladesine; D000242:Cyclic AMP
Régression des tumeurs cutanées expérimentales de la souris sous l'effet de deux dérivés de l'acide adénosine-3',5'-monophosphorique